DIEPENBEEK, Belgium, May 8, 2012 /PRNewswire/ -- Local ROCK Inhibition Highly Effective in Lowering IOP in Glaucoma Model While Avoiding Hyperemia Amakem

SOPHIA ANTIPOLIS, France and MADISON, N.J., March 13, 2012 /PRNewswire/ -- Bausch + Lomb, the global eye health company, and NicOx S.A. (NYSE Euronext Paris: COX) today

TAMPA, Fla., Sept.

PITTSBURGH, April 4, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S.

RESEARCH TRIANGLE PARK, N.C., March 7, 2011 /PRNewswire/ -- Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.